A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of TB001 in Healthy Subjects
Clinical trial NCT05308940 · COMPLETED
Trial details
- NCT number
- NCT05308940
- Sponsor
- Shenzhen Turier Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-10
- Primary completion
- 2022-08-23
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.